Propanc Biopharma Inc (PPCB)
0.0007
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Propanc Biopharma Total Liabilities (Quarterly): 3.806M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.806M |
| September 30, 2023 | 3.170M |
| June 30, 2023 | 3.178M |
| March 31, 2023 | 3.085M |
| December 31, 2022 | 3.023M |
| September 30, 2022 | 2.862M |
| June 30, 2022 | 3.105M |
| March 31, 2022 | 3.117M |
| December 31, 2021 | 3.040M |
| September 30, 2021 | 2.369M |
| June 30, 2021 | 3.081M |
| March 31, 2021 | 3.032M |
| December 31, 2020 | 3.649M |
| September 30, 2020 | 3.313M |
| June 30, 2020 | 3.740M |
| March 31, 2020 | 4.911M |
| December 31, 2019 | 5.737M |
| September 30, 2019 | 4.739M |
| June 30, 2019 | 4.403M |
| March 31, 2019 | 3.673M |
| December 31, 2018 | 4.617M |
| September 30, 2018 | 5.641M |
| June 30, 2018 | 6.823M |
| March 31, 2018 | 6.884M |
| December 31, 2017 | 7.278M |
| Date | Value |
|---|---|
| September 30, 2017 | 6.90M |
| June 30, 2017 | 5.537M |
| March 31, 2017 | 4.760M |
| December 31, 2016 | 3.976M |
| September 30, 2016 | 1.985M |
| June 30, 2016 | 2.944M |
| March 31, 2016 | 5.144M |
| December 31, 2015 | 4.864M |
| September 30, 2015 | 3.488M |
| June 30, 2015 | 3.681M |
| March 31, 2015 | 2.161M |
| December 31, 2014 | 1.930M |
| September 30, 2014 | 1.836M |
| June 30, 2014 | 1.522M |
| March 31, 2014 | 1.165M |
| December 31, 2013 | 1.062M |
| September 30, 2013 | 1.257M |
| June 30, 2013 | 0.7942M |
| March 31, 2013 | 0.752M |
| December 31, 2012 | 0.6555M |
| September 30, 2012 | 0.6367M |
| June 30, 2012 | 0.5842M |
| March 31, 2012 | 0.4822M |
| December 31, 2011 | 0.3543M |
| June 30, 2011 | 0.3068M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.369M
Minimum
Sep 2021
5.737M
Maximum
Dec 2019
3.545M
Average
3.170M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Humanigen Inc | 54.84M |
| Cantabio Pharmaceuticals Inc | 2.215M |
| Affymax Inc | -- |
| Statera BioPharma Inc | 22.92M |
| Incannex Healthcare Inc | 3.112M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.2419M |
| Shareholders Equity (Quarterly) | -3.564M |